Finzati - Logo
MTVA logo

MetaVia Inc.

MTVA • Biotechnology
$1.75
▼ -0.09 (-4.89%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$4.16M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.04Healthy liquidity · 1.93Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 14, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$1.75
Change-4.89%
Market Cap$4.16M
52W Range0.97 - 19.03
Beta0.92
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.04
Current Ratio1.93
Quick Ratio1.93
Volume907.49K

Investment DNA

How strong this company looks for long-term investors

45
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
80/100
Why this score▼
Manageable debt level · 0.04Healthy liquidity · 1.93Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 8/5/2016
Industry: Biotechnology
P/B i: 2.79
Debt / Equity i: 0.04
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.04
Current Ratio: 1.93
Quick Ratio: 1.93
Status: Good

Insider Transactions

Recent executive and insider activity

Glickman Mark A
Transaction: 06/08/2026
BUY
Change
+17,186
Price
Not reported
Filing
06/08/2026
Type
BUY
KOVEN ANDREW I
Transaction: 06/08/2026
BUY
Change
+17,186
Price
Not reported
Filing
06/08/2026
Type
BUY
GROVES JASON L
Transaction: 06/08/2026
BUY
Change
+17,186
Price
Not reported
Filing
06/08/2026
Type
BUY